USPTO serial 50135696
RAMTHRIGA
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- GALLOWAY, JAMILLA ESPY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RAMTHRIGA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New Brunswick, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cheryl L. Foytlin
Cheryl L. Foytlin Johnson & JohnsonOne Johnson & Johnson PlazaNew Brunswick, NJ 08933United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 27, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2026 | NWAP | NEW APPLICATION ENTERED | — |